Giancarlo Agnelli, MD


Professor Agnelli received his medical degree from the University of Perugia. He was a Research and Clinical Fellow at the Department of Medicine, McMaster University, Hamilton, Ontario, Canada, and at the Academic Medical Centre, University of Amsterdam, The Netherlands.

Professor Agnelli was a member of the Conference on Antithrombotic and Thrombolytic Treatment of the American College of Chest Physicians (ACCP) 4th to 8th editions.

He is a member of the Editorial Board of Thrombosis Research, Haemostasis, Journal of Cardiovascular Medicine, Acta Cardiologica, and Trends in Medicine. Professor Agnelli also is a reviewer for the New England Journal of Medicine, The Lancet, Circulation, Blood, Cardiovascular Research, Journal of Thrombosis and Haemostasis and the Journal of the American College of Cardiology.

He has authored more than 300 publications in peer-reviewed international journals.


  • Professor, Internal Medicine
    University of Perugia
    Director, Internal and Cardiovascular Medicine and Stroke-Unit
    University Hospital
    Perugia, Italy

Kenneth Bauer, MD


Dr. Bauer received an MD from the Stanford University School of Medicine in Stanford, California. He completed residency in medicine at the University of Chicago Hospitals and Clinics in Illinois. He was a Fellow in Medical Oncology and a Clinical/Research Fellow in the Division of Thrombosis and Hemostasis at Dana Farber Cancer Institute and was also a Clinical/Research Fellow in the Hematology-Oncology Division at Beth Israel Hospital, Boston, Massachusetts.

Dr Bauer’s research interests include development and clinical evaluation of sensitive new assays for the detection of hypercoagulable states, definition and elucidation of the mechanisms leading to the development of a prethrombotic state, and clinical evaluation of new antithrombotic drugs.

Dr Bauer served as immediate past-Chairman of the Council of the International Society on Thrombosis and Haemostasis (ISTH) and was previously Chairman of the Subcommittee on Predictive Haemostatic Variables in Vascular Diseases of the ISTH.

Dr Bauer has published over 200 original reports, reviews, and book chapters.


  • Professor, Medicine
    Harvard Medical School
    Chief, Hematology Section
    VA Boston Healthcare System
    Director, Thrombosis Clinical Research
    Beth Israel Deaconess Medical Center
    Boston, Massachusetts



Professor Camm's research interests include clinical electrocardiology, clinical cardiac electrophysiology, cardiac arrhythmias, implantable devices for rhythm control, risk stratification for sudden death in patients with ischemic heart disease, for thromboembolism in patients with atrial fibrillation, and for ventricular arrhythmia in patients with cardiomyopathy and channelopathy, adverse cardiovascular events in new and old drugs, and anticoagulation.

Professor Camm holds the European Society of Cardiology Gold Medal.

He is a board member of the European Heart Rhythm Association, the World Society of Arrhythmias, and the Drug Safety Research Unit. He is president of the Arrhythmia Alliance, and founder and trustee of the Atrial Fibrillation Association.

He is editor-in-chief of Clinical Cardiology and EP-Europace and an editor of the European Heart Journal and the European Society of Cardiology Textbook of Cardiovascular Medicine.


  • Professor, Clinical Cardiology
    St. George’s University of London
    Honorary Consultant Cardiologist
    St. George’s Hospital
    London, United Kingdom

Christopher Granger, MD, FACC, FAHA


Dr. Granger earned an MD from the University of Connecticut School of Medicine. He completed an Internal Medicine residency at the University of Colorado Department of Medicine and a Cardiology residency at Duke University Medical Center.

He is certified by the American Board of Internal Medicine, Internal Medicine.

Dr. Granger is a Fellow of the American College of Cardiology, the American Heart Association, and of the European Society of Cardiology.

He is Associate Editor of the American Heart Journal and serves on the editorial board of the Journal of the American College of Cardiology.


  • Professor, Medicine, Cardiology
    Duke University
    Director, Cardiac Care Unit
    Durham, North Carolina

Sylvia Haas, MD, PhD


Dr. Haas studied at the University of Freiburg and the University of Munich.

Professor Haas’s interests include the development of antithrombotics, monitoring of anticoagulants, biomarkers, tumour-associated thrombosis, and the prevention and treatment of thromboembolism.

She is a member of the International Society on Thrombosis and Haemostasis, the International Society of Angiology, the European Society for Surgical Research, and the German Societies of Surgery, Angiology, and Thrombosis and Haemostasis Research. She is a fellow of the Southern African Society of Thrombosis and Haemostasis and is a member of several editorial boards for peer-reviewed journals.


  • Emeritus Professor, Medicine
    Haemostasis and Thrombosis Research Group
    Institute for Experimental Oncology and Therapy Research
    Technical University of Munich
    Munich, Germany

Lord Ajay Kakkar, BSc, MBBS, PhD, FRCS


Professor. Kakkar was educated at Alleyn's School, King's College London (BSc Basic Medical Science with Pharmacology and MBBS, 1988), and the Imperial College London (PhD).

He has research interests in the prevention and treatment of venous thromboembolic disease and cancer-associated thrombosis and, in particular, the role of antithrombotic therapy in prolonging survival in cancer and the role of coagulation serine proteases in tumor biology.

Kakkar is Chair of the Clinical Quality Directorate of University College London Partners Academic Health Science Partnership, Director of the Thrombosis Research Institute in London and lectures and publishes widely on his specialty.

He has worked with the NHS on its strategy to prevent venous thromboembolism (VTE).

Among the awards Kakkar has received are Hunterian Professor, Royal College of Surgeons of England, the David Patey Prize, Surgical Research Society of Great Britain and Ireland, the Knoll William Harvey Prize, International Society on Thrombosis and Haemostasis, and the James IV Association of Surgeons Fellow.

He is a Commissioner of the Royal Hospital Chelsea, Chair of the Board of Governors at Alleyn's School in Dulwich, and a Trustee of the Dulwich Estate.

Professor Kakkar was created a life peer in 2010 as Baron Kakkar, of Loxbeare in the County of Devon, and introduced in the House of Lords the same day. He sits on the crossbenches. He is Chairman of the House of Lords Appointments Commission.

He is a member of the Athenaeum Club.

Kakkar has been noted for his work promoting British business as an ambassador for the United Kingdom.


  • Professor, Surgery
    University College London
    Consultant Surgeon, University College London Hospitals NHS Foundation Trust
    Chair, Quality
    University College London Partners
    Thrombosis Research Institute
    London, England

Craig Kessler, MD


A graduate of Tulane School of Medicine, Dr. Kessler completed his specialty training in hematology and oncology at The Johns Hopkins Hospital.

An international expert in the area of disorders of coagulation, Dr. Kessler has a particular interest in hemophilia. He also has expertise in the treatment of hematologic malignancies.


  • Professor, Medicine and Pathology
    Section Chief, Hematology
    Director, Coagulation Laboratory
    Georgetown University Medical Center
    Washington, DC

Gerald Soff, MD


Dr. Soff founded Angiogen LLC, and Angiogenesis Research Industries. He is a widely respected physician and scientist in the field of angiogenesis and angiogenesis inhibition. He serves as Director of Angiogen.

He is an author of several significant publications about angiogenesis, angiogenesis inhibition, Angiostatin4.5, and other medical research.

He spent five years as a research fellow at the Massachusetts Institute of Technology and is a former Fulbright Fellow. Dr. Soff graduated from Johns Hopkins Medical School and completed Fellowship training in Hematology/Oncology at Harvard University.


  • Chief, Hematology Service
    Memorial Sloan Kettering Cancer Center
    New York, New York

Alexander Turpie, MB, FRCP, FACP, FACC, FRCPC


Dr. Tuprie received his medical education from the University of Glasgow, Scotland, was a clinical research fellow at Glasgow Royal Infirmary and Stobhill General Hospital, and lectured at the University of East Africa Medical School, Nairobi, Kenya.

Professor Turpie’s research interests include new antithrombotic drugs for the management of venous and arterial thrombosis, and anticoagulant therapy in patients with prosthetic heart valves.

He has served on numerous committees and is a frequent lecturer at professional meetings worldwide. Professor Turpie has authored more than 700 articles, abstracts, book chapters, and books, and he has been a reviewer for many international journals, in addition to serving on the editorial boards of Vascular Medicine and Heart Drug.


  • Professor, Medicine
    McMaster University
    Hamilton Health Sciences
    Hamilton, Ontario, Canada